Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.77    0.02 (1.14%)
Bid:
1.61
Ask:
1.77
Spread: 0.16 (9.938%)
Market Cap: £35.51m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Morocco Update

22 May 2023 07:00

RNS Number : 1668A
Quadrise PLC
22 May 2023
 

22 May 2023

Quadrise Plc ("Quadrise" or the "Company")

Morocco Update

Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its fuel trial in Morocco.

The industrial demonstration test commenced as planned this week in accordance with the client's production schedule. Quadrise personnel at the client site confirmed the MSAR® and bioMSAR™ fuel quality and fully commissioned the Company's pumping and heating unit ("PHU") at load.

Cold start-up of the client's combustion unit was carried out and the initial unit warm-up sequence was tested using MSAR® fuel. Unfortunately, whilst running at 100% a mechanical component in the PHU failed progressively, reducing the available unit load achievable from the Quadrise burner, and we were unable to complete the testing during May as originally planned. The parties agreed to pause the trial so that the client could complete their scheduled production run, and the respective Quadrise part could be replaced.

The replacement mechanical item concerned has been procured in the UK by Quadrise and will be sent to the client in Morocco as soon as possible. This will enable Quadrise to finalise optimisation of combustion at full load when the trial resumes.

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

 

"We are obviously disappointed not to have completed the trial during May due to an unexpected mechanical issue in our PHU. However, a replacement part has been purchased and expedited so that we can restart the operational production test at the next opportunity.

On behalf of the Quadrise team on site, we would like to thank our client in Morocco for their valuable and collaborative support during testing to date, and we look forward to returning and completing the test fully during the next production run with their team."

 

For additional information, please contact:

 

Quadrise Fuels International Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

 

Learn more at: www.quadrise.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGUGDUDSDDGXD
Date   Source Headline
18th Feb 20137:00 amRNSHolding(s) in Company
14th Feb 20135:34 pmRNSHolding(s) in Company
13th Feb 201310:31 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSThird Quarter Interim Management Statement
4th Feb 20134:04 pmRNSTotal Voting Rights
4th Feb 20133:59 pmRNSDirector/PDMR Shareholding
29th Jan 20134:05 pmRNSHolding(s) in Company
25th Jan 201310:15 amRNSHolding(s) in Company
24th Jan 201310:17 amRNSHolding(s) in Company
16th Jan 20134:25 pmRNSHolding(s) in Company
9th Jan 20133:08 pmRNSDirector/PDMR Shareholding
14th Dec 201210:24 amRNSHolding(s) in Company
3rd Dec 201211:46 amRNSTotal Voting Rights
3rd Dec 201211:18 amRNSBlocklisting Interim Review
3rd Dec 201210:39 amRNSDirector/PDMR Shareholding
26th Nov 201210:03 amRNSHolding(s) in Company
26th Nov 20127:00 amRNSResults for the six months ended 30 September 2012
13th Nov 201211:51 amRNSNotice of Results
6th Nov 201212:19 pmRNSAdditional Listing
1st Nov 20121:22 pmRNSTotal Voting Rights
1st Nov 20121:15 pmRNSDirector/PDMR Shareholding
31st Oct 20125:42 pmRNSHolding(s) in Company
31st Oct 20124:19 pmRNSHolding(s) in Company
31st Oct 20124:17 pmRNSHolding(s) in Company
4th Oct 201212:30 pmRNSHolding(s) in Company
1st Oct 201210:17 amRNSTotal Voting Rights
1st Oct 201210:14 amRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSDirectorate Change
21st Sep 20128:37 amRNSHolding(s) in Company
11th Sep 20121:34 pmRNSDirector/PDMR Shareholding
31st Aug 20122:52 pmRNSTotal Voting Rights
31st Aug 20122:51 pmRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSInterim Management Statement
24th Jul 20127:00 amRNSAppointment of new Finance Director
23rd Jul 20123:05 pmRNSResult of AGM
23rd Jul 20122:27 pmRNSEGM Statement
20th Jul 20125:29 pmRNSDirector/PDMR Shareholding
16th Jul 20123:00 pmRNSWembley Analyst and Investor presentation
13th Jul 20123:33 pmRNSDirector/PDMR Shareholding
4th Jul 20128:00 amRNSNew joint venture with Hong Kong investor
2nd Jul 20122:07 pmRNSAnnual Information Update
25th Jun 201212:34 pmRNSAnnual Financial Report
25th Jun 201210:41 amRNSDirector/PDMR Shareholding
20th Jun 20122:43 pmRNSHolding(s) in Company
19th Jun 20121:56 pmRNSDirector/PDMR Shareholding
18th Jun 20127:01 amRNSJoint Venture to develop Greenwich Peninsula
12th Jun 20122:27 pmRNSHolding(s) in Company
6th Jun 20121:34 pmRNSHolding(s) in Company
31st May 20124:11 pmRNSHolding(s) in Company
30th May 20121:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.